Reis, Henning; Al-Ahmadie, Hikmat; Gaisa, Nadine T.; Lopez-Beltran, Antonio; Maclean, Fiona; Tsuzuki, Toyonori; Werneck da Cunha, Isabela; Amin, Mahul B.; Aning, Jonathan; Aron, Manju; Athanazio, Daniel; Bambury, Richard M.; Cheng, Liang; Gopalan, Anuradha; Gulmann, Christian; Guo, Charles C.; Harris, Carole; Iyer, Gopa; Jimenez, Rafael E.; Jinzaki, Masahiro; Kikuchi, Eiji; Lal, Priti; Miyai, Kosuke; Netto, George J.; Pan, Chin-Chen; Panebianco, Valeria; van Rhijn, Bas W. G.; Siefker-Radtke, Arlene; Smith, Steven C.; Szarvas, Tibor; Wobker, Sara E.; Kristiansen, Glen; Paner, Gladell P.

Comparison of glass-based and whole-slide image-based grade assignment for clear-cell and papillary renal cell carcinoma: a multi-cohort, international reproducibility study

基于玻璃和全切片图像的分级分配比较：透明细胞和乳头状肾细胞癌的多队列、国际可重复性研究

Histopathology

IF4.1

2025-10-310

PRE

DKK3 Initially Preserves Acinar Integrity Through MEK-Fos Signaling, but Later Switches to an Oncogenic Role in Pancreatic Cancer

DKK3通过MEK-Fos信号通路最初保持腺泡完整性，但随后转变为在胰腺癌中的致癌作用。

Advanced Science

IF14.1

2025-10-280

OAAI

Characterization of ITIH6, a novel inter-α-inhibitor family member with prognostic significance in cholangiocarcinoma

ITIH6的表征：一种具有胆管癌预后意义的 novel inter-α-inhibitor家族成员

International Journal of Biological Macromolecules

IF8.5

2025-10-160

OAAI

Pathologist-like explainable AI for interpretable Gleason grading in prostate cancer

病理学家式可解释AI用于前列腺癌可解释的Gleason分级

Nature Communications

IF15.7

2025-10-080

OAAI

Gesa Mittmann; Sara Laiouar-Pedari; Hendrik A. Mehrtens; Sarah Haggenmüller; Tabea-Clara Bucher; Tirtha Chanda; Nadine T. Gaisa; Mathias Wagner; Gilbert Georg Klamminger; Tilman T. Rau; Christina Neppl; Eva Maria Compérat; Andreas Gocht; Monika Haemmerle; Niels J. Rupp; Jula Westhoff; Irene Krücken; Maximilian Seidl; Christian M. Schürch; Marcus Bauer; Wiebke Solass; Yu Chun Tam; Florian Weber; Rainer Grobholz; Jaroslaw Augustyniak; Thomas Kalinski; Christian Hörner; Kirsten D. Mertz; Constanze Döring; Andreas Erbersdobler; Gabriele Deubler; Felix Bremmer; Ulrich Sommer; Michael Brodhun; Jon Griffin; Maria Sarah L. Lenon; Kiril Trpkov; Liang Cheng; Fei Chen; Angelique Levi; Guoping Cai; Tri Q. Nguyen; Ali Amin; Alessia Cimadamore; Ahmed Shabaik; Varsha Manucha; Nazeel Ahmad; Nidia Messias; Francesca Sanguedolce; Diana Taheri; Ezra Baraban; Liwei Jia; Rajal B. Shah; Farshid Siadat; Nicole Swarbrick; Kyung Park; Oudai Hassan; Siamak Sakhaie; Michelle R. Downes; Hiroshi Miyamoto; Sean R. Williamson; Tim Holland-Letz; Christoph Wies; Carolin V. Schneider; Jakob Nikolas Kather; Yuri Tolkach; Titus J. Brinker

Pathological Risk Stratification of Non-Muscle-Invasive and Muscle-Invasive Urothelial Carcinoma for Optimal Therapeutic Decision-Making

Aktuelle Urologie

IF0.4

2025-10-010

PRE

Treatment outcome of NSCLC patients with BRAFnon-V600E mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany

德国国家基因组医学网络（nNGM）肺癌项目中，BRAF非-V600E突变型非小细胞肺癌患者的治疗效果：一项回顾性、多中心分析

ESMO Open

IF8.3

2025-07-140

OAAI

Oncolytic virotherapy provides a potent therapy option for squamous bladder cancer